The Structural Interface between HIV-1 Vif and Human APOBEC3H.

Area of Science:

• Virology
• Molecular Biology
• Structural Biology

Background:

• Human APOBEC3H (A3H) is a key antiviral protein that restricts HIV-1 replication.
• The HIV-1 Vif protein counteracts A3H by targeting it for proteasomal degradation.
• Understanding the Vif-A3H interaction is critical for developing novel HIV-1 therapeutics.

Purpose of the Study:

• To elucidate the molecular interface between human APOBEC3H (A3H) and HIV-1 Vif.
• To generate a structural model of the A3H-Vif complex.
• To identify potential drug targets for inhibiting HIV-1 replication.

Main Methods:

• Functional mapping of A3H mutants to identify Vif-binding sites.
• Viral adaptation and Vif mutants to identify reciprocal interaction points.
• Structure modeling based on identified interaction sites and experimental validation.

Main Results:

• The Vif-binding site on A3H was mapped to its α3 and α4 helices.
• A structural model revealed A3H helices interacting with the Vif β-sheet (β2-β5).
• The A3H and A3G binding sites on Vif are largely distinct, with Vif β-strand 2 being crucial for both.

Conclusions:

• A Vif-A3H interaction model was successfully generated, explaining previous observations.
• The distinct Vif-A3H interface offers a potential target for novel anti-HIV-1 drug development.
• This model provides insights into HIV-1 evasion mechanisms and host-pathogen interactions.